Nelociguat

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNelociguat
Drug Alias Name奈洛西呱nelociguatumnelociguat奈罗昔夸BAY-98-7081 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsHeart FailureErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNetherlandsItaly +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsHeart FailureErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A